EarningsORIONPHARM
ORIONPHARM Earnings Update
Announcement summary
- What happened
- ORIONPHARM published a corporate disclosure on 30 April 2018. Read the full announcement for details.
- Company
- Orion Pharma Ltd.
- Announcement published
Original announcement
(Q3 Un-audited): Consolidated EPS was Tk. 0.69 for January-March 2018 as against Tk. 0.56 for Jan.-Mar. 2017; Consolidated EPS was Tk. 2.76 for July'17-March'18 as against Tk. 3.02 for July'16-March'17. Consolidated NOCFPS was Tk. 8.57 for July'17-March'18 as against Tk. 8.54 for July'16-March'17. Consolidated NAV per share (including and excluding Revaluation Surplus) was Tk. 72.07 and Tk. 63.71 respectively as on March 31, 2018 as against Tk. 70.95 and Tk. 62.48 respectively as on June 30, 2017.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616acef05a6b00004005cd5f
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from ORIONPHARM
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.